CollPlant Biotechnologies (CLGN) Short-term Investments (2021 - 2025)

CollPlant Biotechnologies (CLGN) has 5 years of Short-term Investments data on file, last reported at $359000.0 in Q4 2025.

• Quarterly Short-term Investments rose 44.76% year-over-year to $359000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $359000.0 (up 44.76% YoY) and the FY2025 annual result came in at $359000.0, up 44.76% from the prior year.
• Short-term Investments improved to $359000.0 in Q4 2025, from $273000.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $30.2 million in Q4 2021 to a low of $23000.0 in Q4 2022.
• A 5-year average of $6.9 million and a median of $248000.0 in 2024 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2022 — Short-term Investments tumbled 99.92% — and 2023, when it soared 947.83%.
• Tracing CLGN's Short-term Investments over 5 years: stood at $30.2 million in 2021, then plunged by 99.92% to $23000.0 in 2022, then soared by 947.83% to $241000.0 in 2023, then increased by 2.9% to $248000.0 in 2024, then soared by 44.76% to $359000.0 in 2025.
• The last three Short-term Investments figures came in at $359000.0 (Q4 2025), $273000.0 (Q2 2025), and $248000.0 (Q4 2024), per Business Quant data.